Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB

Molecular Nutrition and Food Research

Volumn 55, Issue 8, 2011, Pages 1207-1218

  Singh, Narendra P ^a   Singh, Udai P ^a   Hegde, Venkatesh L ^a   Guan, Hongbing ^a   Hofseth, Lorne ^b   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Lymphoma; NF B; Resveratrol; SIRT1

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; SIRT1 PROTEIN, MOUSE; SIRTUIN 1; STILBENE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; MICE; MICE, INBRED NOD; MICE, SCID; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; SIRTUIN 1; STILBENES;

MUS;

EID: 79961091823     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000576     Document Type: Article

References (55)

1. Jang, J. H., Surh, Y. J., Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 2001, 496, 181-190.
2. Gehm, B. D., McAndrews, J. M., Chien, P. Y., Jameson, J. L., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 14138-14143.
3. Soleas, G. J., Diamandis, E. P., Goldberg, D. M., Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 1997, 11, 287-313.
4. Kopp, P., Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French paradox"? Eur. J. Endocrinol. 1998, 138, 619-620.
5. Dorrie, J., Gerauer, H., Wachter, Y., Zunino, S. J., Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 2001, 61, 4731-4739.
6. Clement, M. V., Hirpara, J. L., Chawdhury, S. H., Pervaiz, S., Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92, 996-1002.
7. Ovesna, Z., Kozics, K., Bader, Y., Saiko, P. et al., Antioxidant activity of resveratrol, piceatannol and 3, 3', 4, 4', 5, 5'-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol. Rep. 2006, 16, 617-624.
8. Cignarella, A., Minici, C., Bolego, C., Pinna, C. et al., Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 322-329.
9. Palsamy, P., Subramanian, S., Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol. 2010, 224, 423-432.
10. Mousa, S. A., Gallati, C., Simone, T., Dier, E. et al., Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions. Aging (Albany NY) 2009, 1, 412-424.
11. Orallo, F., Trans-resveratrol: a magical elixir of eternal youth? Curr. Med. Chem. 2008, 15, 1887-1898.
12. Harikumar, K. B., Kunnumakkara, A. B., Sethi, G., Diagaradjane, P. et al., Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int. J. Cancer 2010, 127, 257-268.
13. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V. et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
14. Mao, Q. Q., Bai, Y., Lin, Y. W., Zheng, X. Y. et al., Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mol. Nutr. Food Res. 2010, 54, 1574-1584.
15. Armour, S. M., Baur, J. A., Hsieh, S. N., Land-Bracha, A. et al., Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany NY) 2009, 1, 515-528.
16. Aggarwal, B. B., Shishodia, S., Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71, 1397-1421.
17. North, B. J., Verdin, E., Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 2004, 5, 224.
18. Deng, C. X., SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 2009, 5, 147-152.
19. Cha, E. J., Noh, S. J., Kwon, K. S., Kim, C. Y. et al., Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin. Cancer Res. 2009, 15, 4453-4459.
20. Wang, R. H., Sengupta, K., Li, C., Kim, H. S. et al., Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008, 14, 312-323.
21. Firestein, R., Blander, G., Michan, S., Oberdoerffer, P. et al., The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008, 3, e2020.
22. Singh, N. P., Hegde, V. L., Hofseth, L. J., Nagarkatti, M., Nagarkatti, P., Resveratrol (trans-3, 5, 4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol. Pharmacol. 2007, 72, 1508-1521.
23. Camacho, I. A., Singh, N., Hegde, V. L., Nagarkatti, M., Nagarkatti, P. S., Treatment of mice with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of fas ligand in thymic stromal cells and consequent apoptosis in T cells. J. Immunol. 2005, 175, 90-103.
24. Singh, U. P., Singh, N. P., Singh, B., Hofseth, L. J. et al., Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 2010, 332, 829-839.
25. Singh, N. P., Nagarkatti, M., Nagarkatti, P. S., Role of dioxin response element and nuclear factor-kappaB motifs in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol. Pharmacol. 2007, 71, 145-157.
26. Gracia-Sancho, J., Villarreal, G., Jr., Zhang, Y., Garcia-Cardena, G., Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc. Res. 2010, 85, 514-519.
27. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H. et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109-1122.
28. Markus, M. A., Morris, B. J., Resveratrol in prevention and treatment of common clinical conditions of aging. Clin. Interv. Aging 2008, 3, 331-339.
29. Yang, J., Kong, X., Martins-Santos, M. E., Aleman, G. et al., Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J. Biol. Chem. 2009, 284, 27042-27053.
30. Rodriguez-Nieto, S., Zhivotovsky, B., Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr. Pharm. Des. 2006, 12, 4411-4425.
31. Testa, U., Riccioni, R., Deregulation of apoptosis in acute myeloid leukemia. Haematologica 2007, 92, 81-94.
32. Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A. et al., Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 2000, 130, 467S-471S.
33. Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J. et al., Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002, 23, 1327-1333.
34. Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B. et al., Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem. Pharmacol. 2007, 74, 1568-1574.
35. Lu, C. C., Chen, J. K., Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J. Cell. Physiol. 2010, 223, 343-351.
36. Lassus, P., Opitz-Araya, X., Lazebnik, Y., Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002, 297, 1352-1354.
37. Su, J. L., Lin, M. T., Hong, C. C., Chang, C. C. et al., Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. Carcinogenesis 2005, 26, 1-10.
38. de Medina, P., Casper, R., Savouret, J. F., Poirot, M., Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J. Med. Chem. 2005, 48, 287-291.
39. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T. et al., Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 1999, 56, 784-790.
40. Albani, D., Polito, L., Batelli, S., De Mauro, S. et al., The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J. Neurochem. 2009, 110, 1445-1456.
41. Sulaiman, M., Matta, M. J., Sunderesan, N. R., Gupta, M. P. et al., Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2010, 298, H833-H843.
42. Tissenbaum, H. A., Guarente, L., Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410, 227-230.
43. Saunders, L. R., Verdin, E., Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007, 26, 5489-5504.
44. Blander, G., Guarente, L., The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73, 417-435.
45. Boily, G., He, X. H., Pearce, B., Jardine, K., McBurney, M. W., SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009, 28, 2882-2893.
46. Huffman, D. M., Grizzle, W. E., Bamman, M. M., Kim, J. S. et al., SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007, 67, 6612-6618.
47. Chu, F., Chou, P. M., Zheng, X., Mirkin, B. L., Rebbaa, A., Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. Cancer Res. 2005, 65, 10183-10187.
48. Bordone, L., Guarente, L., Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 2005, 6, 298-305.
49. Peck, B., Chen, C. Y., Ho, K. K., Di Fruscia, P. et al., SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol. Cancer Ther. 2010, 9, 844-855.
50. Yi, J., Luo, J., SIRT1 and p53, effect on cancer, senescence and beyond. Biochim. Biophys. Acta 2010, 1804, 1684-1689.
51. Kwon, H. S., Brent, M. M., Getachew, R., Jayakumar, P. et al., Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe 2008, 3, 158-167.
52. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D. et al., Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
53. Gao, X., Xu, Y. X., Divine, G., Janakiraman, N. et al., Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J. Nutr. 2002, 132, 2076-2081.
54. Liu, H. S., Pan, C. E., Yang, W., Liu, X. M., Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World. J. Gastroenterol. 2003, 9, 1474-1476.
55. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G. et al., Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001, 61, 7456-7463.